# Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer

> **NCT01160419** · PHASE2 · UNKNOWN · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 49 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Docetaxel 50 mg/m2, 1-hour-Infusion, day 1
- **DRUG:** Oxaliplatin 85 mg/m², 2-hour-Infusion, day 1
- **DRUG:** Folinic acid 200 mg/m², 1-2-hour-Infusion, day 1
- **DRUG:** 5-FU 2600 mg/m², 24-hour-Infusion, day 1

## Key facts

- **NCT ID:** NCT01160419
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2011-05
- **Final completion:** 2014-05
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2010-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160419, "Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01160419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*